Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nasdaq Biotechnology Ishares ETF (NQ: IBB )

135.11 USD UNCHANGED
Streaming Delayed Price Updated: 5:44 PM EDT, Oct 26, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Nasdaq Biotechnology Ishares ETF

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
T2108 Update – A Second Epic Oversold Period Over the Past Five Months
As it turned out, T2108 and the S&P 500 (SPY) did manage to drop even lower before staging a massive comeback. T2108 bounced back from a low of 3.8% to close at 7.4%. The low was a 7+ year low. 
Tags Currencies/Forex Stocks / Equities
From Blogs - TalkMarkets
Markets Become A Casino Spectacle
The most shorted and oversold sector (Biotech) began to rally today with the Dow down over 500 points as a "take-no-prisoners" short squeeze was underway. This naturally spilled over to the rest of... 
Tags Bonds Healthcare Gold/Precious Metals
From Blogs - TalkMarkets
Biotech Rally Underway After Hitting 52 Week Low Today… Update-After Close
Biotech stocks reversed course about noon after the worse start in many years. 
Tags ETF's Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
The Weekly Play: Sell Calls on This Sector (IBB)
 
Tags NASDAQ:GILD Trading Advice NASDAQ:IBB
From InvestorPlace - Latest Headlines
Early And Late Rally Wasted Buying Power?
Markets rallied at the open Monday as China data its markets and Emerging Markets on the belief the government there will add fresh stimulus. 
Tags Capital & Industrial Goods Bonds Energy
From Blogs - TalkMarkets
iShares Nasdaq Biotechnology Getting Very Oversold
In trading on Tuesday, shares of the iShares Nasdaq Biotechnology ETF (IBB) entered into oversold territory, changing hands as low as $273.06 per share. We define oversold territory using the Relative... 
Tags ETFs
From ETF Channel
Smart Money Highlights Oversold Stocks in Small Cap Biotechs
Tags Business & Professional Services
From ACCESSWIRE
Valuation Models For Large Cap Biopharma Stocks In A Bear Market
We have been in a bear market for biotechnology stocks since September 2015 despite a Q4 rally; now add to that the recent 2016 YTD correction of 16% bringing prices topre-bubble lows 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
The iShares Nasdaq Biotechnology Index (ETF) (IBB) Is Ready to Bounce!
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips The IBB ETF of biotech stocks has reached support levels that could spark a better bounce. Active investors should take... 
Tags Stock Market Today NASDAQ:IBB
From Stock Picks – InvestorPlace
The iShares Nasdaq Biotechnology Index (ETF) (IBB) Is Ready to Bounce!
 
Tags Stock Market Today NASDAQ:IBB
From InvestorPlace - Latest Headlines
7 Battered Biotech Stocks: Bargains or Busts?
 
Tags Hot Stocks NASDAQ:AMGN NASDAQ:CELG
From InvestorPlace - Latest Headlines
T2108 Update – The "Hold Your Nose And Buy" Oversold Moment
The percentage of stocks trading above their respective 40-day moving averages (DMAs), sank to rare single-digit territory. 
Tags Stocks / Equities ETF's
From Blogs - TalkMarkets
7 Battered Biotech Stocks: Bargains or Busts?
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks have suffered big losses in 2016. Some are great buying opportunities, but the rest are just disasters. The... 
Tags NASDAQ:GILD NASDAQ:REGN NASDAQ:CELG
From Stock Picks – InvestorPlace
Fast Money Picks For January 13
OnCNBC's Fast Money Final Trade, Tim Seymour said he wants to be in defensive stocks with proven earnings and a good ... 
Tags Media David Seaburg Guy Adami
From Benzinga
Short-Term Oversold Market Finds A Pulse
After serious sell-off some market sectors stage a quiet rally. Mostly bigger names and sectors saw some buying while other beaten down sectors and names barely budged off their lows. 
Tags Energy Gold/Precious Metals ETF's
From Blogs - TalkMarkets
J.P.Morgan Healthcare Conference #1: Investors Move Into Life Science Stocks-Bouncing Off The Bottom
We have a long way to recover in this bear market. The IBB? touched near 52 week lows yesterday at $287 and is currently at $296 after a failed bounce then a recovery. We are down about 12% over five... 
Tags Stocks / Equities Basic Materials / Commodities Technology
From Blogs - TalkMarkets
Your first trade for Wednesday, January 13
The "Fast Money" traders give their final trades of the day. 
Tags Investing/Wall Street Investing/Stock Market Consumer Discretionary/Retail/Specialty Retail/Apparel Retail
From CNBC.com News
This Chart Suggests An 18% Drop In The S&P 500
Technical analysis suggests that the S&P 500 can drop 18% from current levels and test support at the old highs of the dot-com bubble and the housing bubble. 
Tags Energy Healthcare Stocks / Equities
From Blogs - TalkMarkets
As biotech stocks knife under their ‘Hillary’ low, analysts still say buy ’em
Biotech stocks have dived to levels last seen in late 2014, in another sign of how the new year has hammered riskier plays. 
Tags Health/Care Commodities Markets/Exchanges
From MarketWatch
Biotech ETFs Look Green on Earnings Concerns
We are heading into the earnings season, and investors are growing concerned over the outlook for biotechnology stocks and sector-related exchange traded funds as bellwether Celgene Corp. (NasdaqGS:... 
Tags XBI IBB Inverse ETFs
From ETF Trends
What Lies Ahead for Biotech ETFs in 2016?
It has been a highly eventful year for the biotech sector thanks to mergers and acquisitions (M&A), deals galore, pricing controversy, stretched valuations and the usual pipeline updates. The NASDAQ... 
Tags Pharma/Biotech ETF's Stocks / Equities
From Blogs - TalkMarkets
Can Large Cap Biopharmaceutical Stocks Outperform In 2016?
With this post we summarize selected Sales and Earnings metrics of important large cap biotech stocks for the purpose of analysis after the J.P. Morgan Healthcare Conference and after 2015 financial... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Regeneron Pharmaceuticals is Now Oversold (REGN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Here's Why There's Been A Rush Of Biotech Offerings
The beginning of the year has started with four consecutive sell-offs in the S&P 500. Sectors have been hit by a bevy topics ... 
Tags EPZM Offerings Biotech
From Benzinga
Biotech Bear Market Rally On Hold: Lackluster Tape For Week One 2016
Biotech stocks are off 5% from year-end 2015 highs and up only 6.73% from 2015 levels on January 6, 2015, the launch date for the great Q1 2015 rally. The small cap weighted XBI had the same general... 
Tags Pharma/Biotech ETF's Stocks / Equities
From Blogs - TalkMarkets
Biotech Winners 2015: Rayno Mid Caps Were Up 29.6%
We previously reviewed the Rayno Small Cap Portfolio which was up 38.1% in Q4 2015 and the Mid-Caps also beat despite a big loss by Clovis Oncology after the FDA required more data on its lung cancer... 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
These are the biotech stocks to own next year: Pro
RBC Capital Markets analyst Michael Yee says there are three biotech stocks to own next year no matter how the sector performs next year. 
Tags Investing/Stock Market Health Care Celgene Corp
From CNBC.com News
The Halftime Report Experts Give Their Top Picks for 2016
On 2015's final day of trading, the Halftime Report experts give their top picks for 2016. 
Tags Qualcomm Inc iShares Nasdaq Biotechnology ETF Investing
From CNBC.com News
Nasdaq Outperforms: 3 ETFs in Focus
While most of the major benchmarks including the Dow and S&P 500 struggled to finish in the green this year, the Nasdaq Composite Index Nasdaq-100 Index have outperformed them to register healthy gains... 
Tags ETF's Technology Consumer Goods
From Blogs - TalkMarkets
Fast Money Picks For December 31
On CNBC's Fast Money Final Trade, Tim Seymour suggested that investors should consider selling Tesoro Corporation (NYSE: ... 
Tags CNBC Brina Kelly Media
From Benzinga
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.